Skip to content
GLP-1 Desk
Menu

Evidence review

How to Choose a GLP-1 Provider That Fits You

A six-point checklist for picking a GLP-1 telehealth provider — price, state access, molecule, speed, support and licensing — matched to your situation.

By The Desk, Provider Intelligence Desk

The telehealth GLP-1 market has gone from a handful of clinics to dozens of look-alike storefronts in under three years. Most sell the same two molecules, at prices that swing more than threefold, under marketing that all reads about the same. Choosing well is less about finding the "best" provider in the abstract and more about matching one to your own constraints. This is the checklist the Desk uses on every review.

Start with the molecule, not the brand

Two drugs anchor this entire category. Semaglutide, the compound in Wegovy, drove a mean weight reduction of roughly 15% of body weight over 68 weeks in its pivotal obesity trial1. Tirzepatide, the compound in Zepbound, went further in its own trial — up to about 21% at the highest dose over 72 weeks2. Most providers offer both. Deciding which molecule you want first narrows the field faster than any other single question, and our semaglutide vs tirzepatide breakdown walks through the trade-off in detail.

Run the six-point checklist

The Desk scores every provider on six measurable dimensions — the same six, every time. You can run the shortlist yourself using the same lens (the full rubric is on our methodology page):

**Price transparency.** Can you see the real monthly cost before handing over an email address? Watch for teaser rates that step up after month one. A flat, all-in number you can plan around beats a low headline that balloons at refill.

**State access.** A provider is only as good as its reach into your state. Some cover all 50; others operate in a short list. Confirm your state is served before anything else — a great program you can't legally use is worth nothing.

**Molecule range.** Does the provider carry both semaglutide and tirzepatide, and can you switch between them on one account without re-onboarding? Optionality matters if your response or tolerance changes.

**Onboarding speed.** How long from sign-up to a shipped first dose? Some clinics move in days; others stall on paperwork. If a fast start matters to you, weight it heavily.

**Support responsiveness.** GLP-1 therapy comes with side effects and dose questions. A provider that answers within a day is worth paying a little more for than one that leaves you on a ticket queue.

**Licensing and trust.** Look for a named, verifiable pharmacy and, ideally, third-party certification such as a LegitScript-verified operator. Anonymity is a red flag. Our guide to whether compounded GLP-1 is legit and safe covers how to vet this properly.

Match the provider to your situation

No single provider wins on all six. The right pick depends on which axis binds you hardest:

- **Budget-first and in a covered state?** Chase the lowest verified flat price. - **Need brand-name Wegovy or Zepbound?** Filter immediately to providers with brand access — most of the board is compounded only. - **Want to avoid needles?** Prioritize oral or sublingual options, covered in our injections vs oral GLP-1 guide. - **Moving states or traveling?** Weight nationwide coverage above almost everything else.

Our best GLP-1 provider by need guide sorts the board into exactly these lanes.

Where the Desk lands

On our board, CoreAge Rx earns the top Desk Score for the reader who wants one thing above all: a verified flat price, both molecules, and all-50-state reach with no step-up traps. That is a specific profile, not a universal verdict. A budget-first reader in a covered state, or someone who needs brand access, may rightly rank a different provider first — which is exactly why we publish the full comparison desk and a head-to-head alternatives view rather than a single name. Use the checklist, weight the axis that matters to you, and let your own constraints pick the winner.

Frequently asked questions

What is the single most important factor when choosing a GLP-1 provider?

Whichever constraint binds you hardest. For most readers it is state access — a provider that does not serve your state is a non-starter regardless of price. After that, price transparency and licensing tend to matter most.

Should I pick a provider based on price alone?

Only if you are in a covered state and comfortable with a compounded, injectable-only program. Price is one of six dimensions; the cheapest option often trades away brand access, oral routes, or support depth.

How do I verify a provider is legitimate?

Look for a named, verifiable dispensing pharmacy and third-party certification such as LegitScript verification. Anonymous pharmacies and prices that require sign-up to view are warning signs.

References

  1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.